American Oriental Bioengineering, Inc. , , a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced that it plans to release fourth quarter and full year 2009 financial results on Monday, March 15, 2010, before the market opens.